CDK2 and acute kidney injury: MiR-21-3p mediates energy metabolism and apoptosis in tubular epithelial cells (TEC) by manipulating the AKT/CDK2-FOXO1 pathway, thereby ameliorating sepsis-associated acute kidney injury (SAKI) progression [36].